Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Brenda Loew, MAc, LAc
Brenda Loew, MAc, LAc, specializes in Toyohari meridian therapy, shonishin (pediatrics) and Manaka treatment approaches at her practice in Seattle, Wash. She is the president of the Toyohari Association of North America, one of the founding members of the Japanese Acupuncture Institute, and has been teaching Japanese-style acupuncture systems since 1994. She can be reached at gentleacupuncture@earthlink.net.